Repository of Research and Investigative Information

Repository of Research and Investigative Information

Ilam University of Medical Sciences

Estimating global injuries morbidity and mortality: methods and data used in the Global Burden of Disease 2017 study

Mon Oct 3 05:51:41 2022

(2020) Estimating global injuries morbidity and mortality: methods and data used in the Global Burden of Disease 2017 study. Injury prevention : journal of the International Society for Child and Adolescent Injury Prevention. ISSN 1475-5785 (Electronic) 1353-8047 (Linking)

Full text not available from this repository.

Official URL: https://www.ncbi.nlm.nih.gov/pubmed/32839249

Abstract

BACKGROUND: While there is a long history of measuring death and disability from injuries, modern research methods must account for the wide spectrum of disability that can occur in an injury, and must provide estimates with sufficient demographic, geographical and temporal detail to be useful for policy makers. The Global Burden of Disease (GBD) 2017 study used methods to provide highly detailed estimates of global injury burden that meet these criteria. METHODS: In this study, we report and discuss the methods used in GBD 2017 for injury morbidity and mortality burden estimation. In summary, these methods included estimating cause-specific mortality for every cause of injury, and then estimating incidence for every cause of injury. Non-fatal disability for each cause is then calculated based on the probabilities of suffering from different types of bodily injury experienced. RESULTS: GBD 2017 produced morbidity and mortality estimates for 38 causes of injury. Estimates were produced in terms of incidence, prevalence, years lived with disability, cause-specific mortality, years of life lost and disability-adjusted life-years for a 28-year period for 22 age groups, 195 countries and both sexes. CONCLUSIONS: GBD 2017 demonstrated a complex and sophisticated series of analytical steps using the largest known database of morbidity and mortality data on injuries. GBD 2017 results should be used to help inform injury prevention policy making and resource allocation. We also identify important avenues for improving injury burden estimation in the future.

Item Type: Article
Creators:
CreatorsEmail
James, S. L.UNSPECIFIED
Castle, C. D.UNSPECIFIED
Dingels, Z. V.UNSPECIFIED
Fox, J. T.UNSPECIFIED
Hamilton, E. B.UNSPECIFIED
Liu, Z.UNSPECIFIED
Roberts, N. L. S.UNSPECIFIED
Sylte, D. O.UNSPECIFIED
Bertolacci, G. J.UNSPECIFIED
Cunningham, M.UNSPECIFIED
Henry, N. J.UNSPECIFIED
LeGrand, K. E.UNSPECIFIED
Abdelalim, A.UNSPECIFIED
Abdollahpour, I.UNSPECIFIED
Abdulkader, R. S.UNSPECIFIED
Abedi, A.UNSPECIFIED
Abegaz, K. H.UNSPECIFIED
Abosetugn, A. E.UNSPECIFIED
Abushouk, A. I.UNSPECIFIED
Adebayo, O. M.UNSPECIFIED
Adsuar, J. C.UNSPECIFIED
Advani, S. M.UNSPECIFIED
Agudelo-Botero, M.UNSPECIFIED
Ahmad, T.UNSPECIFIED
Ahmed, M. B.UNSPECIFIED
Ahmed, R.UNSPECIFIED
Eddine Aichour, M. T.UNSPECIFIED
Alahdab, F.UNSPECIFIED
Alanezi, F. M.UNSPECIFIED
Alema, N. M.UNSPECIFIED
Alemu, B. W.UNSPECIFIED
Alghnam, S. A.UNSPECIFIED
Ali, B. A.UNSPECIFIED
Ali, S.UNSPECIFIED
Alinia, C.UNSPECIFIED
Alipour, V.UNSPECIFIED
Aljunid, S. M.UNSPECIFIED
Almasi-Hashiani, A.UNSPECIFIED
Almasri, N. A.UNSPECIFIED
Altirkawi, K.UNSPECIFIED
Abdeldayem Amer, Y. S.UNSPECIFIED
Andrei, C. L.UNSPECIFIED
Ansari-Moghaddam, A.UNSPECIFIED
CA, T. AntonioUNSPECIFIED
Anvari, D.UNSPECIFIED
Yaw Appiah, S. C.UNSPECIFIED
Arabloo, J.UNSPECIFIED
Arab-Zozani, M.UNSPECIFIED
Arefi, Z.UNSPECIFIED
Aremu, O.UNSPECIFIED
Ariani, F.UNSPECIFIED
Arora, A.UNSPECIFIED
Asaad, M.UNSPECIFIED
Ayala Quintanilla, B. P.UNSPECIFIED
Ayano, G.UNSPECIFIED
Ayanore, M. A.UNSPECIFIED
Azarian, G.UNSPECIFIED
Badawi, A.UNSPECIFIED
Badiye, A. D.UNSPECIFIED
Baig, A. A.UNSPECIFIED
Bairwa, M.UNSPECIFIED
Bakhtiari, A.UNSPECIFIED
Balachandran, A.UNSPECIFIED
Banach, M.UNSPECIFIED
Banerjee, S. K.UNSPECIFIED
Banik, P. C.UNSPECIFIED
Banstola, A.UNSPECIFIED
Barker-Collo, S. L.UNSPECIFIED
Barnighausen, T. W.UNSPECIFIED
Barzegar, A.UNSPECIFIED
Bayati, M.UNSPECIFIED
Bazargan-Hejazi, S.UNSPECIFIED
Bedi, N.UNSPECIFIED
Behzadifar, M.UNSPECIFIED
Belete, H.UNSPECIFIED
Bennett, D. A.UNSPECIFIED
Bensenor, I. M.UNSPECIFIED
Berhe, K.UNSPECIFIED
Bhagavathula, A. S.UNSPECIFIED
Bhardwaj, P.UNSPECIFIED
Bhat, A. G.UNSPECIFIED
Bhattacharyya, K.UNSPECIFIED
Bhutta, Z. A.UNSPECIFIED
Bibi, S.UNSPECIFIED
Bijani, A.UNSPECIFIED
Boloor, A.UNSPECIFIED
Borges, G.UNSPECIFIED
Borschmann, R.UNSPECIFIED
Borzi, A. M.UNSPECIFIED
Boufous, S.UNSPECIFIED
Braithwaite, D.UNSPECIFIED
Briko, N. I.UNSPECIFIED
Brugha, T.UNSPECIFIED
Budhathoki, S. S.UNSPECIFIED
Car, J.UNSPECIFIED
Cardenas, R.UNSPECIFIED
Carvalho, F.UNSPECIFIED
Castaldelli-Maia, J. M.UNSPECIFIED
Castaneda-Orjuela, C. A.UNSPECIFIED
Castelpietra, G.UNSPECIFIED
othersUNSPECIFIED
Keywords: descriptive epidemiology methodology populations/contexts statistical issues submitted work. Dr. Driscoll reports grants from World Health Organisation, during the conduct of the study. Dr Shariful Islam is funded by a Fellowship from National Heart Foundation of Australia and Institute for Physical Activity and Nutrition, Deakin University. Dr. Ivers reports grants from National Health and Medical Research Council of Australia, during the conduct of the study. Dr. Jozwiak reports personal fees from TEVA, personal fees from ALAB, personal fees from BOEHRINGER INGELHEIM, personal fees from SYNEXUS, non-financial support from SERVIER, non-financial support from MICROLIFE, non-financial support from MEDICOVER, outside the submitted work. Walter Mendoza is currently Program Analyst Population and Development at the Peru Country Office of the United Nations Population Fund-UNFPA, which does not necessarily endorses this study. Dr. Rakovac reports grants from World Health Organization, during the conduct of the study. Dr. Sheikh reports grants from Health Data Research UK, outside the submitted work. Dr. Singh reports personal fees from Crealta/Horizon, Medisys, Fidia, UBM LLC, Trio health, Medscape, WebMD, Clinical Care options, Clearview healthcare partners, Putnam associates, Spherix, Practice Point communications, the National Institutes of Health and the American College of Rheumatology, personal fees from Speaker's bureau of Simply Speaking. Dr. Singh owns stock options in Amarin pharmaceuticals and Viking pharmaceuticals. Dr. Singh serves on the steering committee of OMERACT, an international organization that develops measures for clinical trials and receives arms-length funding from 12 pharmaceutical companies. Dr. Singh serves on the FDA Arthritis Advisory Committee. Dr. Singh is a member of the Veterans Affairs Rheumatology Field Advisory Committee. Dr. Singh is the editor and the Director of the UAB Cochrane Musculoskeletal Group Satellite Center on Network Meta-analysis, outside the submitted work. Dr. Stein reports personal fees from Lundbeck and Sun, outside the submitted work.
Divisions:
Journal or Publication Title: Injury prevention : journal of the International Society for Child and Adolescent Injury Prevention
Journal Index: Pubmed
Identification Number: https://doi.org/10.1136/injuryprev-2019-043531
ISSN: 1475-5785 (Electronic) 1353-8047 (Linking)
Depositing User: مهندس مهدی شریفی
URI: http://eprints.medilam.ac.ir/id/eprint/3111

Actions (login required)

View Item View Item